Skip to main content
. 2022 Mar 31;13:843515. doi: 10.3389/fimmu.2022.843515

Figure 8.

Figure 8

Prognostic validation of FMI in BC patients undergoing different treatment regimens. K-M analyses of OS in BC patients undergoing chemotherapy (A, B), endocrinotherapy (C, D), and radiotherapy (E, F) between high- and low-FMI groups in METABRIC and TCGA-BRCA cohorts, respectively. FMI, fatty acid metabolism index; BC, breast cancer; K-M, Kaplan–Meier; OS, overall survival; METABRIC, Molecular Taxonomy of Breast Cancer International Consortium; TCGA, The Cancer Genome Atlas.